MALAT1 lncRNA and Parkinson’s Disease: The role in the Pathophysiology and Significance for Diagnostic and Therapeutic Approaches
Authors:
- 4 June 2022
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 59 (9) , 5253-5262
Abstract
Parkinson’s disease (PD) is the second most common age-related neurodegenerative disorder. PD is characterized by progressive loss of dopamine-producing neurons in the substantia nigra (SN) region of brain tissue followed by the α-synuclein-based Lewy bodies’ formation. These conditions are manifested by various motor and non-motor symptoms such as resting tremor, limb rigidity, bradykinesia and posture instability, cognitive impairment, sleep disorders, and emotional and memory dysfunctions. Long non-coding RNAs (lncRNAs) are closely related to protein-coding genes and are involved in various biological processes. Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) lncRNA is involved in different pathways, including alternative splicing, transcriptional regulation, and post-transcriptional regulation, and also interacts with RNAs as a miRNA sponge. MALAT1 is highly expressed in brain tissues and several lines of evidence suggested it is probably involved in synapse generation and other neurophysiological pathways. This narrative review discussed all aspects of MALAT1-associated mechanisms involved in the PD pathogenesis, i.e., perturbed α-synuclein homeostasis, apoptosis and autophagy, and neuro-inflammation. Lastly, the possible applications of MALAT1 as a diagnostic biomarker and its importance to developing therapeutic strategies were highlighted. The literature search was conducted using neurodegeneration, neurodegenerative disorders, Parkinson’s disease, lncRNA, and MALAT1 as search items in Google Scholar, Web of Knowledge, PubMed, and Scopus up to December 2021.Keywords
This publication has 96 references indexed in Scilit:
- Long Noncoding RNA MALAT1 Controls Cell Cycle Progression by Regulating the Expression of Oncogenic Transcription Factor B-MYBPLOS Genetics, 2013
- The role of autophagy in Parkinson's disease: rotenone-based modelingBehavioral and Brain Functions, 2013
- Emerging roles of non-coding RNAs in brain evolution, development, plasticity and diseaseNature Reviews Neuroscience, 2012
- DGCR8 HITS-CLIP reveals novel functions for the MicroprocessorNature Structural & Molecular Biology, 2012
- The Role of Autophagy in Parkinson's DiseaseCold Spring Harbor Perspectives in Medicine, 2012
- A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNACell, 2011
- A long nuclear‐retained non‐coding RNA regulates synaptogenesis by modulating gene expressionThe EMBO Journal, 2010
- Long non-coding RNAs: insights into functionsNature Reviews Genetics, 2009
- 3′ End Processing of a Long Nuclear-Retained Noncoding RNA Yields a tRNA-like Cytoplasmic RNACell, 2008
- Specific expression of long noncoding RNAs in the mouse brainProceedings of the National Academy of Sciences, 2008